10 Videos +PDF
Runtime around 15-20 HOurs
Overview
Cleveland Clinic Nephrology Update 2024 Thank you for joining your colleagues for the Cleveland Clinic Nephrology Update 2024. This year’s update will provide a review of the most up-to-date data and analyze it for implications in clinical practice, as well as focus on the most recent current topics that impact your practice. Cleveland Clinic Nephrology Update 2024 features experts that will address diagnosis and management strategies for patients with kidney disease.
Target Audience
This activity is designed for nephrologists, rheumatologists, cardiologists, hepatologists, intensive care specialists, internists, nurses, nurse practitioners, physician assistants, and all other clinicians who care for these patients.
Learning Objectives
- Describe the role of precision medicine in the care of patients with genetic kidney diseases, and describe the major hereditary renal syndromes.
- Summarize the most recent advances in the treatment of polycystic kidney disease.
- Identify the management strategies of hepatorenal syndrome, including therapies such as MARS, Terlipressin, and CRRT.
- Describe and critically appraise several updates in nephrology, including future therapies of C3GN, the pathogenesis and management of IgA nephropathy, and the major advances in the field of kidney transplantation.
- Identify controversies in the management of ANCA-associated vasculitis as well as the role of emerging therapies.
- Describe the role of the complement pathway in the development of thrombotic microangiopathy.
- Recognize the different facets of glomerular disease management beyond immuno-modulatory therapy.
- Summarize the emerging pharmacological and procedural therapies in hypertension management.
- Review the clinical guidelines for screening and management of primary hyperaldosteronism.
- Examine the updated management guidelines for obesity management in CKD patients, including the role of SGLT2i and GLP1-RA.
Topics
| Thursday 18 April Top |
| 3:00 PM – 4:30 PM |
| Cleveland Clinic Nephrology Update Journal Club |
| Jagmeet Dhingra MD , Jonathan Taliercio DO |
| 5:15 PM – 5:20 PM |
| Welcome |
| Ali Mehdi MD, MEd |
| 5:20 PM – 6:00 PM |
| Precision Medicine: Genetics and Nephrology |
| Arlene Chapman MD |
| 6:00 PM – 6:40 PM |
| Genetics Program Overview: Pre/Post Counseling |
| Mary-Beth Roberts MS, CGC |
| 6:40 PM – 7:20 PM |
| ADPKD Update |
| Arlene Chapman MD |
| 7:20 PM – 8:00 PM |
| Genetics in Tubulointerstitial/Atypical Cystic Disease/ Kidney Stones |
| Xiangling Wang MD, PhD |
| 8:00 PM – 8:10 PM |
| Questions and Answers |
| Arlene Chapman MD , Xiangling Wang MD, PhD , Mary-Beth Roberts MS, CGC |
| Friday 19 April Top |
| 8:00 AM – 8:40 AM |
| HRS Update |
| Andrew Allegretti MD, MSC |
| 8:40 AM – 9:20 AM |
| Cardiac Axis in HRS: The Hepato-Cardio-Renal Syndrome |
| Andrew Allegretti MD, MSC |
| 9:20 AM – 10:00 AM |
| Case Discussions in AKI and Cirrhosis in the ICU: MARS/Terlipressin/RRT |
| Anchal Kapoor MD , Andrew Allegretti MD, MSC , Christina Lindenmeyer MD |
| 10:00 AM – 10:10 AM |
| Questions and Answers |
| Anchal Kapoor MD , Andrew Allegretti MD, MSC , Christina Lindenmeyer MD |
| 10:25 AM – 11:15 AM |
| Kasperzak Lecture: Lupus Nephritis Update |
| Brad Rovin MD, FACP, FASN |
| 11:15 AM – 11:50 AM |
| Clinicopathologic Case Discussions |
| Marc A. Pohl MD , Corey Cavanaugh DO , Richard Glassock MD, MACP , Brad Rovin MD, FACP, FASN , Leal Herlitz MD |
| 11:50 AM – 12:00 PM |
| Questions and Answers |
| Marc A. Pohl MD , Corey Cavanaugh DO , Richard Glassock MD, MACP , Brad Rovin MD, FACP, FASN , Leal Herlitz MD |
| 1:00 PM – 1:40 PM |
| Update on C3 Glomerulopathy |
| Carla Nester MD, MSA, FASN |
| 1:40 PM – 2:25 PM |
| IgA Nephropathy Update |
| Richard Glassock MD, MACP |
| 2:25 PM – 3:10 PM |
| ANCA Vasculitis: Update on Management and Controversies |
| Carol Langford MD |
| 3:10 PM – 3:20 PM |
| Questions and Answers |
| Carol Langford MD , Carla Nester MD, MSA, FASN , Richard Glassock MD, MACP |
| 3:40 PM – 4:20 PM |
| Nephrology-Rheumatology Case Discussions |
| Emily Littlejohn DO, MPH , Carol Langford MD , Corey Cavanaugh DO , Brad Rovin MD, FACP, FASN |
| 4:20 PM – 5:00 PM |
| Thrombotic Microangiopathy and Complement Immunology |
| Carla Nester MD, MSA, FASN |
| 5:00 PM – 5:40 PM |
| Clinicopathologic Case Discussions |
| Marc A. Pohl MD , Carla Nester MD, MSA, FASN , Richard Glassock MD, MACP , Brad Rovin MD, FACP, FASN , Leal Herlitz MD |
| 5:40 PM – 6:20 PM |
| Prophylaxis in Glomerular Diseases |
| Corey Cavanaugh DO |
| Saturday 20 April Top |
| 8:00 AM – 8:45 AM |
| Emerging Pharmacologic Therapies in Hypertension |
| George Thomas MD |
| 8:45 AM – 9:30 AM |
| Prescribing GLP1-RA and SGLT2i: A Practical Guide for the Nephrologist |
| Kevin Pantalone DO |
| 9:30 AM – 9:40 AM |
| Questions and Answers |
| Kevin Pantalone DO , George Thomas MD |
| 10:00 AM – 10:45 AM |
| Procedural Therapies for Hypertension: An Update |
| Luke Laffin MD |
| 10:45 AM – 11:30 AM |
| Challenging Hypertension Cases: Panel Discussion |
| Luke Laffin MD , George Thomas MD |
| 11:30 AM – 11:45 AM |
| Questions and Answers |
| Luke Laffin MD , George Thomas MD |
| 1:00 PM – 1:45 PM |
| Obesity and CKD |
| Sankar Navaneethan MD, MS, MPH |
| 1:45 PM – 2:30 PM |
| Update on Obesity Management |
| Bartolome Burguera MD, PhD |
| 2:30 PM – 2:40 PM |
| Questions and Answers |
| Bartolome Burguera MD, PhD , Sankar Navaneethan MD, MS, MPH |
| 3:00 PM – 3:40 PM |
| Update on Hyperaldosteronism |
Reviews
There are no reviews yet.